Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel
NCT00527449
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Primary Breast Cancer
Interventions
DRUG:
Epirubicin, Carboplatin, Docetaxel
Sponsor
Klinikum Weissenfels